...
首页> 外文期刊>Journal of molecular graphics & modelling >Identification of potent urease inhibitors via ligand- and structure-based virtual screening and in vitro assays
【24h】

Identification of potent urease inhibitors via ligand- and structure-based virtual screening and in vitro assays

机译:通过基于配体和结构的虚拟筛选和体外测定鉴定有效的脲酶抑制剂

获取原文
获取原文并翻译 | 示例

摘要

A pharmacophore model was developed based on three structurally diverse urease inhibitors by using the GASP program. This model comprises the positions and tolerance for two acceptor atoms (AA1 and AA2), one donor atom (DA1), and one hydrophobic center (HYP1). This derived phamacophore model was employed to screen an in-house database of organic compounds. Hits obtained were evaluated by molecular docking using GOLD software. On the basis of ligand- and structural-based predictions, an in vitro testing of short-listed compounds was conducted and a novel class of urease inhibitors (2-aminothiophines) was identified. The potent in vitro activity and selectivity of these compounds, along with their non-toxic nature against the plant cells indicated that they can serve as leads for solving urease-associated health and agriculture problems.
机译:使用GASP程序,基于三种结构多样的脲酶抑制剂,开发了一个药效团模型。该模型包括两个受主原子(AA1和AA2),一个供体原子(DA1)和一个疏水中心(HYP1)的位置和耐受性。该推导的生晶团模型用于筛选有机化合物的内部数据库。使用GOLD软件通过分子对接评估获得的命中数。根据基于配体和结构的预测,对入围化合物进行了体外测试,并确定了新型的脲酶抑制剂(2-氨基噻吩)。这些化合物的有效体外活性和选择性以及它们对植物细胞的无毒性质表明,它们可以作为解决脲酶相关的健康和农业问题的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号